logo

Quick Facts

Share

Genmab A/S announced that results from the Phase III study of Arzerra or ofatumumab plus bendamustine did not meet the primary endpoint of improved progression-free survival or PFS in patients with indolent B-cell non-Hodgkin's lymphoma (iNHL) who were unresponsive to rituximab or a rituximab-containing...

Babcock & Wilcox Enterprises, Inc. (BW) confirmed that it had received a non-binding indication of interest from Steel Partners to acquire B&W in a transaction in which B&W shareholders would receive between $3.00 and $3.50 per share in cash. Steel Partners beneficially owns 17.8 percent of B&W's outstanding...

SMA Solar Technology AG (SMTGF.PK) announced its Managing Board confirmed the company's sales and earnings guidance for the 2018 fiscal year, which forecasts sales of between 900 million and 1 billion euros and EBITDA of between 90 million and 110 million euros. At the Annual General Meeting, the...

Clorox Co. (CLX) said its board of directors has authorized the company to repurchase its stock in the open market for an aggregate purchase price of up to $2 billion. Clorox noted that the stock repurchase program is designed to return value to its stockholders and is in addition to the company's...

AbbVie (ABBV) announced that the Phase 3 iLLUMINATE (PCYC-1130) trial met its primary endpoint of improvement in progression-free survival (PFS). The study evaluated IMBRUVICA (ibrutinib) in combination with GAZYVA (obinutuzumab) in previously untreated chronic lymphocytic leukemia or small lymphocytic...

Elliott Management Corporation sent a letter to the Board of Directors of athenahealth, Inc. (ATHN) following up on Elliott's recent proposal to acquire athenahealth for $160 per share in cash. The letter aggregated for the Board the outpouring of positive reactions to Elliott's offer specifically...

Responding to George Feldenkreis' letter to the Perry Ellis Board of Directors on May 23, 2018, The Special Committee of the Perry Ellis International (PERY) said Thursday that no decision has been made with respect to the Company's response to the Feldenkreis Proposal. There is no assurance the Feldenkreis...

Visa Inc. (V) said it has made a strategic investment in YellowPepper, a mobile payments provider in Latin America, to help accelerate adoption of mobile payments and tokenization in Latin America and the Caribbean. The strategic investment, the first of its kind for Visa in the region. Visa and...

AstraZeneca (AZN.L, AZN) announced the company will be sharing its R&D momentum at ASCO with seven "Best of ASCO" presentations and 14 oral presentations from a total of 91 accepted abstracts. These presentations will showcase AstraZeneca's four scientific platforms: Immuno-Oncology, DNA Damage Response,...

Celgene Corp. (CELG) announced that its board authorized the repurchase of an additional $3 billion of the Company's common stock. In addition, the company plans to enter into an accelerated share repurchase agreement to repurchase an aggregate of $2 billion of the Company's common stock. The planned...

Brady Corp. (BRC) reported that its net earnings for the third quarter ended April 30, 2018 rose to $26.0 million from $22.6 million in the same quarter last year. Earnings per Class A Nonvoting Common Share were $0.49 for the third quarter of fiscal 2018, compared to $0.43 in the same quarter last...

McKesson Corp. (MCK) announced its Board has approved an additional share repurchase authorization of $4 billion, as the company believes that its shares are an attractive investment opportunity and repurchasing stock is an important part of its diversified capital allocation strategy. Fourth-quarter...

Hormel Foods Corp. (HRL), a leading global branded food company, reported that its net earnings attributable to the company for the second quarter of fiscal 2018 rose to $237.38 million or $0.44 per share from last year's $210.93 million or $0.39 per share. Analysts polled by Thomson Reuters expected...

Stage Stores, Inc. (SSI) reported a first-quarter net loss of $31.7 million compared to a loss of $19.0 million, prior year. Loss per share was $1.14 compared to a loss per share of $0.70. First-quarter net sales were $344 million compared to $309 million, a year ago. Comparable sales decreased 2.8%...

Royal Bank of Canada (RY, RY.TO) reported second-quarter net income of C$3.06 billion, up 9% from the prior year with double-digit EPS growth of 11% to C$2.06. The company said its results reflect strong earnings growth in Wealth Management, Personal & Commercial Banking, and Investor & Treasury Services,...

Follow RTT